It extensively covers applications of NPDDS, including lipid nanoparticles for dermal applications, nanocarriers for treating restenosis, ocular, central nervous system, and gastrointestinal applications, and as an adjuvant for vaccine development.
With contributions from international experts, this guide discusses:
• formulation for poorly soluble drugs
• biological requirements for nanotherapeutic applications and the role of nanobiotechnology in developing nanomedicine
• advances in nanoparticulate technology, including electrospining, formation of microcystals, production of liquid crystalline phases, and the technology of metallic nanoparticles